Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. human proteomics
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Human Proteomics Articles & Analysis

4 news found

Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

Gene therapy programs for Huntington’s disease and multiple systems atrophy are currently enrolling patients into first-in-human studies. The strategic collaboration with Mammoth Biosciences, Inc., with its groundbreaking gene-editing technology as a key enabling technology as well as a stand-alone therapeutic modality, will significantly enhance Bayer’s efforts to ...

ByBayer AG


Creative Proteomics Launches Oncology Multi-omics Platform to Promote Basic Oncology Research

Creative Proteomics Launches Oncology Multi-omics Platform to Promote Basic Oncology Research

Currently, there are two main ideas and modes of mass spectrometry-based proteomics research: differential comparative proteomics and identification proteomics. CES University Graduate School in Medellin, Colombia conducted a study of human and bacterial proteomic profiles in bile exposed to tumor and non-tumor ...

ByCreative Proteomics


AptaMatrix, Inc. Receives a NIH Small Business Innovation Research Phase II Award

AptaMatrix, Inc. Receives a NIH Small Business Innovation Research Phase II Award

This assay aims to provide deep analysis of the human plasma proteome for detection and characterization of novel prostate cancer biomarkers. ...

ByAptaMatrix, Inc.


Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome

Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome

In addition to the clinical development of specific plasma fractions and protein inhibitors, Alkahest is focused on developing a complete understanding of the human plasma proteome. This unique proteomic platform of targets will help Grifols and Alkahest to unlock new therapeutics and diagnostics, develop new plasma proteins, new indications for ...

ByAlkahest, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT